Semaglutide
US$ 21.33
glp 1 mental health Reassuring' findings suggest GLP-1 receptor agonists do not increase suicide risk GLP-1 Use Not Linked to
Description
These delays highlight the structural barriers that can slow adoption in populations with higher rates of comorbidities
95% CI 0.89, 0.96) and all-cause mortality rate (HR 0.70
Note: Anti-Obesity GLP-1s Wegovy and Zepbound, Anti-Diabetes GLP-1s Ozempic and Mounjaro Source: IQVIA MAAS Patient Behavior Library Tool
Features & Benefits
Stuck on your GLP-1 journey
A retrospective disproportionality analysis was conducted using the reporting odds ratio (ROR) on FAERS data (20042024), with Bayesian confidence propagation neural network (BCPNN) employed for sensitivity analysis
